{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:04:30Z","timestamp":1784329470854,"version":"3.55.0"},"reference-count":30,"publisher":"Societatea Romana de Morfologie","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rom J Morphol Embryol"],"published-print":{"date-parts":[[2026,7,10]]},"abstract":"<jats:p>Background and Objectives: Colorectal adenocarcinoma (CR ADK) may show either a uniform architectural pattern or intratumoral architectural heterogeneity, but the clinicopathological relevance of these growth patterns is still insufficiently characterized. Aim: The study\u2019s aim was to compare the clinical and morphological profiles of tumors with a single dominant architectural pattern and tumors with two coexisting architectural patterns. Patients, Materials and Methods: We analyzed 104 CR ADKs, divided into two groups: one group of 78 patients with a single architectural pattern all over the tumor and one group of 26 patients with two architectural patterns within the tumor. Clinical parameters and morphological parameters (macroscopic and microscopic) were comparatively assessed using, for categorical variables, the \u03c72 (chi-squared) test and, for continuous variables Student\u2019s t-test. Results: Tumors with a single morphological appearance were found in males of around 65 years old, from urban areas, located especially in the distal regions of the colon, usually circumferential and greater than 5 cm. Morphologically, they were usually fungated and ulcerative common forms of ADK with moderate degree of differentiation and, overall, with a somewhat less aggressive biological behavior. Tumors with two morphological aspects, in turn, were found often in old women, in the proximal regions of the colon and most often circumferential but with smaller dimensions than those in the first group. Morphologically, they were usually protrusive with ulcerations on the surface. Although the usually encountered patter was that of common form of well-differentiated ADK, in the deep areas, they assumed poorly differentiated forms, most often with mucinous-type secretory properties. Aggressiveness markers like intratumor necrosis or inflammation were a common presence. The biological behavior was more aggressive, especially with the invasion of regional lymph nodes. Conclusions: Our study identified a subgroup of colon epithelial malignancies with two main architectural patterns that presented distinctive clinical-morphological features and a trend toward greater biological aggressiveness, particularly through deeper mucinous\/poorly differentiated transformation and more frequent necro-inflammatory changes. Further studies are necessary to include this tumor profile in routine prognostic assessment of colorectal epithelial malignancies.<\/jats:p>","DOI":"10.47162\/rjme.67.1.12","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:55:06Z","timestamp":1784328906000},"page":"117-128","source":"Crossref","is-referenced-by-count":0,"title":["Architectural patterns of growth of colon adenocarcinoma \u2013 comparative study"],"prefix":"10.47162","volume":"67","author":[{"name":"Department of Medical Assistance, Faculty of Medical Care, Titu Maiorescu University of Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liviu","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Mit\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Medical Semiology, University of Medicine and Pharmacy of Craiova, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iancu Emil","family":"Ple\u015fea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Doctoral School, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; Department of Pathology, Bagdasar\u2013Arseni Emergency Clinical Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecil Sorin","family":"Mirea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of General Surgery, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Erchid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Doctoral School, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana-Roxana","family":"Lazarovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Radiology and Medical Imaging, Emergency County Hospital, Craiova, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminia Diana","family":"Ciob\u0103noiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Doctoral School, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"26736","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"\"[1] Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2024, 74(3):229-263. https:\/\/doi.org\/10.3322\/caac.21834","DOI":"10.3322\/caac.21834"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"[2] Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut, 2017, 66(4):683-691. https:\/\/doi.org\/10.1136\/gutjnl-2015-310912","DOI":"10.1136\/gutjnl-2015-310912"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"[3] Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin, 2023, 73(1):17-48. https:\/\/doi.org\/10.3322\/caac.21763","DOI":"10.3322\/caac.21763"},{"key":"ref3","unstructured":"[4] World Health Classification (WHO) Classification of Tumours Editorial Board. Digestive system tumours. 5th edition, vol. 1, International Agency for Research on Cancer (IARC) Press, Lyon, France, 2019."},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"[5] Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol, 2018, 15(2):81-94. https:\/\/doi.org\/10.1038\/nrclinonc.2017.166","DOI":"10.1038\/nrclinonc.2017.166"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"[6] B\u00fcttner J, J\u00f6hrens K, Klauschen F, Hummel M, Lenze D, Saeger W, Lehmann A. Intratumoral morphological heterogeneity can be an indicator of genetic heterogeneity in colorectal cancer. Exp Mol Pathol, 2018, 104(1):76-81. https:\/\/doi.org\/10.1016\/j.yexmp.2018.01.007","DOI":"10.1016\/j.yexmp.2018.01.007"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"[7] Ueno H, Jones AM, Wilkinson KH, Jass JR, Talbot IC. Histological categorisation of fibrotic cancer stroma in advanced rectal cancer. Gut, 2004, 53(4):581-586. https:\/\/doi.org\/10.1136\/gut.2003.028365","DOI":"10.1136\/gut.2003.028365"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"[8] Bertillot F, Herv\u00e9 S, Drobjazko N, Kedei N, Gendi ME, Hernandez MO, Kruse K, Erkan EP, Binner M, Punovuori K, Pellinen T, Ahtiainen M, B\u00f6hm J, Mecklin JP, Haglund C, Hagstr\u00f6m J; iCAN; Nikolaev M, Gjorevski N, L\u00fctolf M, Sepp\u00e4l\u00e4 TT, Wickstr\u00f6m SA, Miroshnikova YA. Colorectal cancer heterogeneity co-evolves with tumor architecture to determine disease outcome. bioRxiv [Preprint], 2025, Aug 13:2025.08.11.669722. https:\/\/doi.org\/10.1101\/2025.08.11.669722","DOI":"10.1101\/2025.08.11.669722"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"[9] Marusyk A, Polyak K. Tumor heterogeneity: causes and consequences. Biochim Biophys Acta, 2010, 1805(1):105-117. https:\/\/doi.org\/10.1016\/j.bbcan.2009.11.002","DOI":"10.1016\/j.bbcan.2009.11.002"},{"key":"ref9","unstructured":"[10] Hamilton SR, Aaltonen LA (eds). Pathology and genetics of tumours of the digestive system. 3rd edition, vol. 2, World Health Classification (WHO) Classification of Tumours, International Agency for Research on Cancer (IARC) Press, Lyon, France, 2000."},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"[11] Jass JR. Molecular heterogeneity of colorectal cancer: implications for cancer control. Surg Oncol, 2007, 16(Suppl 1):S7-S9. https:\/\/doi.org\/10.1016\/j.suronc.2007.10.039","DOI":"10.1016\/j.suronc.2007.10.039"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"[12] Wang Z, Ma L, Cao J, Chen X, Chang X, Ma R, Lv H, Zhang Z, Li H, Jiang T. Intratumor heterogeneity score reveals immune landscape and prognostic implications in colorectal cancer. Front Immunol, 2026, 16:1671148. https:\/\/doi.org\/10.3389\/fimmu.2025.1671148","DOI":"10.3389\/fimmu.2025.1671148"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"[13] Losi L, Ponti G, Di Gregorio C, Marino M, Rossi G, Pedroni M, Benatti P, Roncucci L, de Leon MP. Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma. Pathol Res Pract, 2006, 202(9):663-670. https:\/\/doi.org\/10.1016\/j.prp.2006.05.003","DOI":"10.1016\/j.prp.2006.05.003"},{"issue":"6","key":"ref13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/00015458.2013.11680951","article-title":"Mucinous differentiation in colorectal cancer: molecular, histological and clinical aspects","volume":"113","author":"Debunne","year":"2013","unstructured":"[14] Debunne H, Ceelen W. Mucinous differentiation in colorectal cancer: molecular, histological and clinical aspects. Acta Chir Belg, 2013, 113(6):385-390.","journal-title":"Acta Chir Belg"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"[15] Hugen N, Brown G, Glynne-Jones R, de Wilt JHW, Nagtegaal ID. Advances in the care of patients with mucinous colorectal cancer. Nat Rev Clin Oncol, 2016, 13(6):361-369. https:\/\/doi.org\/10.1038\/nrclinonc.2015.140","DOI":"10.1038\/nrclinonc.2015.140"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"[16] Ono Y, Yilmaz O. Emerging and under-recognised patterns of colorectal carcinoma morphologies: a comprehensive review. J Clin Pathol, 2024, 77(7):439-451. https:\/\/doi.org\/10.1136\/jcp-2023-208816","DOI":"10.1136\/jcp-2023-208816"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"[17] Aydin \u0130C, Torun M, S\u00f6nmez MR, Ademo\u011flu S, Sunar AO, Uzun O, G\u00fclmez S, Polat E, Duman M. The influence of mucinous histology on the prognosis of stage II and III colorectal cancers. Medicina (Kaunas), 2025, 61(3):456. https:\/\/doi.org\/10.3390\/medicina61030456","DOI":"10.3390\/medicina61030456"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"[18] Jernvall P, M\u00e4kinen MJ, Karttunen TJ, M\u00e4kel\u00e4 J, Vihko P. Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers. Eur J Cancer, 1999, 35(2):197-201. https:\/\/doi.org\/10.1016\/s0959-8049(98)00306-2","DOI":"10.1016\/S0959-8049(98)00306-2"},{"key":"ref18","unstructured":"[19] Greenson JK, Lauwers GY, Montgomery EA, Owens SR, Polydorides AD, Srivastava A (eds). Diagnostic pathology: gastrointestinal. 2nd edition, Elsevier, Philadelphia, PA, USA, 2016."},{"key":"ref19","unstructured":"[20] Bosman FT, Carneiro F, Hruban RH, Theise ND (eds). World Health Classification (WHO) Classification of tumours of the digestive system. 4th edition, vol. 3, International Agency for Research on Cancer (IARC) Press, Lyon, France, 2010."},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"[21] Wagner SJ, Reisenb\u00fcchler D, West NP, Niehues JM, Zhu J, Foersch S, Veldhuizen GP, Quirke P, Grabsch HI, van den Brandt PA, Hutchins GGA, Richman SD, Yuan T, Langer R, Jenniskens JCA, Offermans K, Mueller W, Gray R, Gruber SB, Greenson JK, Rennert G, Bonner JD, Schmolze D, Jonnagaddala J, Hawkins NJ, Ward RL, Morton D, Seymour M, Magill L, Nowak M, Hay J, Koelzer VH, Church DN; TransSCOT Consortium; Matek C, Geppert C, Peng C, Zhi C, Ouyang X, James JA, Loughrey MB, Salto-Tellez M, Brenner H, Hoffmeister M, Truhn D, Schnabel JA, Boxberg M, Peng T, Kather JN. Transformer-based biomarker prediction from colorectal cancer histology: a large-scale multicentric study. Cancer Cell, 2023, 41(9):1650-1661.e4. https:\/\/doi.org\/10.1016\/j.ccell.2023.08.002","DOI":"10.1016\/j.ccell.2023.08.002"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"[22] Kather JN, Pearson AT, Halama N, J\u00e4ger D, Krause J, Loosen SH, Marx A, Boor P, Tacke F, Neumann UP, Grabsch HI, Yoshikawa T, Brenner H, Chang-Claude J, Hoffmeister M, Trautwein C, Luedde T. Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. Nat Med, 2019, 25(7):1054-1056. https:\/\/doi.org\/10.1038\/s41591-019-0462-y","DOI":"10.1038\/s41591-019-0462-y"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"[23] Echle A, Grabsch HI, Quirke P, van den Brandt PA, West NP, Hutchins GGA, Heij LR, Tan X, Richman SD, Krause J, Alwers E, Jenniskens J, Offermans K, Gray R, Brenner H, Chang-Claude J, Trautwein C, Pearson AT, Boor P, Luedde T, Gaisa NT, Hoffmeister M, Kather JN. Clinical-grade detection of microsatellite instability in colorectal tumors by deep learning. Gastroenterology, 2020, 159(4):1406-1416.e11. https:\/\/doi.org\/10.1053\/j.gastro.2020.06.021","DOI":"10.1053\/j.gastro.2020.06.021"},{"key":"ref23","unstructured":"[24] National Cancer Institute (NCI) at National Institutes of Health (NIH). Tumor grade. NCI, Bethesda, MD, USA, last updated: August 1, 2022."},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"[25] Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med, 1990, 113(10):779-788. https:\/\/doi.org\/10.7326\/0003-4819-113-10-779","DOI":"10.7326\/0003-4819-113-10-779"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"[26] Missiaglia E, Jacobs B, D'Ario G, Di Narzo AF, Soneson C, Budinska E, Popovici V, Vecchione L, Gerster S, Yan P, Roth AD, Klingbiel D, Bosman FT, Delorenzi M, Tejpar S. Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features. Ann Oncol, 2014, 25(10):1995-2001. https:\/\/doi.org\/10.1093\/annonc\/mdu275","DOI":"10.1093\/annonc\/mdu275"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"[27] Yamauchi M, Lochhead P, Morikawa T, Huttenhower C, Chan AT, Giovannucci E, Fuchs C, Ogino S. Colorectal cancer: a tale of two sides or a continuum? Gut, 2012, 61(6):794-797. https:\/\/doi.org\/10.1136\/gutjnl-2012-302014","DOI":"10.1136\/gutjnl-2012-302014"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"[28] Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell, 2011, 144(5):646-674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"[29] Afr\u0103s\u00e2nie VA, Gafton B, Marinca MV, Alexa-Stratulat T, Miron L, Rusu C, Ivanov AV, Balan GG, Croitoru AE. The coexistence of RAS and BRAF mutations in metastatic colorectal cancer: a case report and systematic literature review. J Gastrointestin Liver Dis, 2020, 29(2):251-256. https:\/\/doi.org\/10.15403\/jgld-1003","DOI":"10.15403\/jgld-1003"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"[30] Leung CAW, Fazzi GE, Melenhorst J, Rennspiess D, Grabsch HI. Acetone clearance of mesocolic or mesorectal fat increases lymph node yield and may improve detection of high-risk Stage II colorectal cancer patients. Colorectal Dis, 2018, 20(11):1014-1019. https:\/\/doi.org\/10.1111\/codi.14335\"","DOI":"10.1111\/codi.14335"}],"container-title":["Romanian Journal of Morphology and Embryology"],"original-title":[],"link":[{"URL":"https:\/\/rjme.ro\/RJME\/resources\/files\/670126117128.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:01:07Z","timestamp":1784329267000},"score":1,"resource":{"primary":{"URL":"https:\/\/rjme.ro\/archive\/67\/1\/12\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,7,12]]},"published-print":{"date-parts":[[2026,7,12]]}},"URL":"https:\/\/doi.org\/10.47162\/rjme.67.1.12","relation":{},"ISSN":["1220-0522","2066-8279"],"issn-type":[{"value":"1220-0522","type":"print"},{"value":"2066-8279","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]}}}